Terrence M. Pegula - 30 Jun 2023 Form 4 Insider Report for Abacus Life, Inc. (ABL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Jul 2023, 16:45:40 UTC
Next SEC filing
17 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Terrence M. Pegula, /s/ Terrence M. Pegula

Key filing fact

Terrence M. Pegula filed Form 4 for Abacus Life, Inc. (ABL) on 10 Jul 2023.

Key facts

  • This page summarizes Terrence M. Pegula's Form 4 filing for Abacus Life, Inc. (ABL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Jul 2023, 16:45.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABL transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+8,615,000
Change %
Price
Shares after
8,615,000
Date
30 Jun 2023
Ownership
See footnotes
Footnotes
F1, F2, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ABL transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares
-8,615,000
Change %
-100%
Price
Shares after
0
Date
30 Jun 2023
Ownership
See footnotes
Underlying class
Class A Common Stock
Underlying amount
8,615,000
Exercise price
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On June 30, 2023, pursuant to that certain Agreement and Plan of Merger, dated as of August 30, 2022, as amended on October 14, 2022 and April 20, 2023, by and among Abacus Life, Inc. (formerly known as East Resources Acquisition Company) (the "Issuer"), LMA Merger Sub, LLC ("LMA Merger Sub"), Abacus Merger Sub, LLC ("Abacus Merger Sub"), Longevity Market Assets, LLC ("LMA") and Abacus Settlements, LLC ("Legacy Abacus"), the Issuer completed its initial business combination (the "Business Combination").

Footnote F2

(Continued footnote 1) As a result of the Business Combination, each outstanding share of Class B Common Stock, par value $0.0001 per share, of the Issuer was automatically converted into a share of Common Stock, par value $0.0001 per share ("Common Stock"), of the Issuer on a one-for-one basis. Upon the completion of the Business Combination, LMA Merger Sub merged with and into LMA, with LMA surviving such merger as a wholly owned subsidiary of the Issuer, Abacus Merger Sub merged with and into Legacy Abacus, with Legacy Abacus surviving such merger as a wholly owned subsidiary of the Issuer, and the Issuer was renamed "Abacus Life, Inc."

Footnote F3

East Sponsor, LLC ("East Sponsor") is the record holder of these securities. East Asset Management, LLC ("East Asset Management") is the managing member of East Sponsor. As a result, East Asset Management may be deemed to share beneficial ownership of the securities held by East Sponsor.

Footnote F4

Trusts controlled by Terrence M. Pegula are the sole members of East Asset Management. As such, Mr. Pegula may be deemed to share beneficial ownership of the securities held by East Sponsor. Mr. Pegula disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .